Browsing by Author Traina, F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 20 of 42  next >
PreviewIssue DateTitleAuthor(s)AdvisorType
2014Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasmsTraina, F; Visconte, V; Elson, P; Tabarroki, A; Jankowska, AM; Hasrouni, E; Sugimoto, Y; Szpurka, H; Makishima, H; O'Keefe, CL; Sekeres, MA; Advani, AS; Kalaycio, M; Copelan, EA; Saunthararajah, Y; Saad, STO; Maciejewski, JP; Tiu, RV-Artigo de periódico
2013Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemiaAbu Kar, S; Jankowska, A; Makishima, H; Visconte, V; Jerez, A; Sugimoto, Y; Muramatsu, H; Traina, F; Afable, M; Guinta, K; Tiu, RV; Przychodzen, B; Sakaguchi, H; Kojima, S; Sekeres, MA; List, AF; McDevitt, MA; Maciejewski, JP-Artigo de periódico
2003The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomasVassallo, J; Metze, K; Traina, F; De Souza, CA; Lorand-Metze, I-Artigo de periódico
2010The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromesReis-Alves, SC; Traina, F; Saad, STO; Metze, K; Lorand-Metze, I-Artigo de periódico
2012Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic MastocytosisTraina, F; Visconte, V; Jankowska, AM; Makishima, H; O'Keefe, CL; Elson, P; Han, YC; Hsieh, FH; Sekeres, MA; Mali, RS; Kalaycio, M; Lichtin, AE; Advani, AS; Duong, HK; Copelan, E; Kapur, R; Saad, STO; Maciejewski, JP; Tiu, RV-Artigo de periódico
2014Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cellsMachado-Neto, JA; Campos, PD; Favaro, P; Lazarini, M; Lorand-Metze, I; Costa, FF; Saad, STO; Traina, F-Artigo de periódico
2006ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cellsTraina, F; Favaro, PMB; Medina, SD; Duarte, ADS; Winnischofer, SMB; Costa, FF; Saad, STO-Artigo de periódico
2014ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cellsMachado-Neto, JA; Lazarini, M; Favaro, P; Franchi, GC; Nowill, AE; Saad, STO; Traina, F-Artigo de periódico
2013IL10 inversely correlates with the percentage of CD8(+) cells in MDS patientsLopes, MR; Traina, F; Campos, PD; Pereira, JKN; Machado-Neto, JA; Machado, HD; Gilli, SCO; Saad, STO; Favaro, P-Artigo de periódico
2003Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with AktFavaro, PMB; Medina, SD; Traina, F; Basseres, DS; Costa, FF; Saad, STO-Artigo de periódico
2008High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophilsAlmeida, CB; Traina, F; Lanaro, C; Canalli, AA; Saad, STO; Costa, FF; Conran, N-Artigo de periódico
2006High expression of FMNL1 protein in T non-Hodgkin's lymphomasFavaro, PMB; Traina, F; Vassallo, J; Brousset, P; Delsol, G; Costa, FF; Saad, STO-Artigo de periódico
2007Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell diseaseCanalli, AA; Franco-Penteado, CF; Traina, F; Saad, STO; Costa, FF; Conran, N-Artigo de periódico
2009VARIATION OF BONE MARROW CD34+ CELL SUBSETS IN MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO TYPESReis, SC; Traina, F; Metze, K; Saad, STO; Lorand-Metze, I-Artigo de periódico
2008Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimensSala-Torra, O; Martin, PJ; Storer, B; Traina, F; Sorror, ML; Storb, R; Sandmaier, BM; Flowers, MED-Artigo de periódico
2013Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell diseaseSakamoto, TM; Canalli, AA; Traina, F; Franco-Penteado, CF; Gambero, S; Saad, STO; Conran, N; Costa, FF-Artigo de periódico
2011Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromesMachado-Neto, JA; Traina, F; Lazarini, M; Campos, PD; Borgia, K; Pagnano, B; Lorand-Metze, I; Costa, FF; Saad, STO-Artigo de periódico
2011Updates in Cytogenetics and Molecular Markers in MDSTiu, RV; Visconte, V; Traina, F; Schwandt, A; Maciejewski, JP-Artigo de periódico
2012Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndromeMachado-Neto, JA; Traina, F; Campos, PD; Andreoli-Risso, MF; Costa, FF; Saad, STO-Artigo de periódico
2014CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12Melo, RDC; Longhini, AL; Bigarella, CL; Baratti, MO; Traina, F; Favaro, P; Campos, PD; Saad, STO-Artigo de periódico